Large-scale testing (Phase 3)UnknownNCT04257175What this trial is testingCAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 ExpressionWho this might be right forAcute Myeloid Leukemia Sheba Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00806767What this trial is testingFludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Institut Paoli-Calmettes 82
Testing effectiveness (Phase 2)Ended earlyNCT03067571What this trial is testingDaratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forHigh Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT00376922What this trial is testingMusic in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Wake Forest University Health Sciences 65
Early research (Phase 1)Looking for participantsNCT04771572What this trial is testingStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.Who this might be right forNon Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more Newave Pharmaceutical Inc 100
Testing effectiveness (Phase 2)Ended earlyNCT00915811What this trial is testingPilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and ThymoglobulinWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, Acute King's College Hospital NHS Trust 20
Testing effectiveness (Phase 2)Ended earlyNCT04113616What this trial is testingAn Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)Who this might be right forRelapsed or Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN) Kartos Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412What this trial is testingSHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)Study completedNCT00303667What this trial is testingDonor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell TransplantWho this might be right forAcute Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334What this trial is testingEfficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia Zwi Berneman 130
Early research (Phase 1)Study completedNCT01034475What this trial is testingStudy to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic MalignanciesWho this might be right forAdvanced Hematologic Malignancies Wake Forest University Health Sciences 26
Early research (Phase 1)Study completedNCT00217412What this trial is testingVorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forChildhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT03537599What this trial is testingDaratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell TransplantWho this might be right forMinimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more Sumithira Vasu 4
Testing effectiveness (Phase 2)Study completedNCT00005801What this trial is testingTotal-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia University of Colorado, Denver
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643636What this trial is testingChidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AMLWho this might be right forAML (Acute Myeloid Leukemia) Dongguan People's Hospital 46
Large-scale testing (Phase 3)UnknownNCT00091234What this trial is testingGemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaWho this might be right forLeukemia European Organisation for Research and Treatment of Cancer - EORTC 279
Testing effectiveness (Phase 2)UnknownNCT01305499What this trial is testingA Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Hetty Carraway 52
Testing effectiveness (Phase 2)Ended earlyNCT00089388What this trial is testingCilengitide in Treating Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+9 more National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00008151What this trial is testingGemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02121418What this trial is testingDecitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative NeoplasmWho this might be right forChronic Myelomonocytic Leukemia-2Myelodysplastic SyndromeMyeloproliferative Neoplasm+1 more University of Washington 12